These results suggest that UroA has a hyperglycemic inhibitory effect on the development of T2D, which may be mediated by a major mechanism involving the induction of GLUT4 membrane translocation via the activation of both PI3K/Akt and AMPK. The gene discussed is SLC2A4; the disease is type 2 diabetes mellitus.